Efficacy and Safety of Coadministered Ezetimibe-Rosuvastatin plus Telmisartan in South Korean Patients with Dyslipidemia and Hypertension: A Multicenter, Randomized, Double-Blind, Active-Controlled, Phase III Trial.

Zhao-Yan SongMoo-Hyun KimHan-Cheol LeeSung-Ji ParkMoo-Yong RheeJong-Il ChoiSang-Hyun KimIn-Ho ChaeYoung-Joon HongNam-Ho LeeGyo-Seung HwangSeung-Ho HurJung-Woo SonJei-Keon ChaeHyo-Soo Kim

Published in: Journal of clinical medicine (2023)

Ezetimibe-rosuvastatin plus telmisartan treatment is effective and safe when compared to either ezetimibe-rosuvastatin or telmisartan.

Keyphrases

phase iii
double blind
placebo controlled
clinical trial
open label
phase ii
blood pressure
study protocol